InsidersTradesSigma
科拓生物 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 科拓生物 share price and the full management transaction log of the company, a listed equity based in China. Shares are listed on CN CN, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 科拓生物 has recorded 6 public disclosures. Market capitalisation: €4.4bn. The latest transaction was reported on 11 December 2025 (Sale). Among the most active insiders: 乔向前. The full history is free.
6
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,950 of 25,564 companies
51.5
score / 100
Value28
Quality75
FCF yld-4.3%
Earn yld2.3%
EV/EBITDA29.3x
ROE4.9%
Gross mgn52%
Net mgn26%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 December 2025
Declarations6 total
6 of 6 declarations